The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...

Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs. The partnership expands Vifor Pharma’s cooperation with Fresenius ...

Aurora™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors. The system separates ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Amicus™ high collection efficiency yields multiple products per donor for the lowest-cost platelet production. It is designed to adapt to the requirements of different collection settings. Let ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

1 Day FRE -2.26% DJIA 0.26% S&P 500 0.33% Health Care/Life Sciences 1.32% ...

Fresenius Medical Care AG & Co. KGaA (FMS) CEO Robert Powell on Q2 2020 Results - Earnings Call Transcript SA Transcripts Thu, Jul. 30, 2020 Fresenius Medical Care AG & Co. KGaA 2020 Q2 - Results ...

NAINR. 2013;13(4):189-195.